David Mott/Definition: Difference between revisions
Jump to navigation
Jump to search
imported>Howard C. Berkowitz (New page: <noinclude>{{Subpages}}</noinclude> Panel of Senior Advisers, Chatham House; Chief Executive and President, MedImmune, USA) |
imported>Howard C. Berkowitz No edit summary |
||
| Line 1: | Line 1: | ||
<noinclude>{{Subpages}}</noinclude> | <noinclude>{{Subpages}}</noinclude> | ||
Panel of Senior Advisers, [[Chatham House]]; Chief Executive and President, [[MedImmune]], USA | General Partner, NEA investments, focused on biopharmaceutical investments; previously President and Chief Executive Officer of MedImmune, subsidiary of AstraZeneca Plc, and Executive Vice President of AstraZeneca; Panel of Senior Advisers, [[Chatham House]]; Chief Executive and President, [[MedImmune]], USA | ||
Latest revision as of 21:49, 11 May 2010
This article contains just a definition and optionally other subpages (such as a list of related articles), but no metadata. Create the metadata page if you want to expand this into a full article.
David Mott [r]: General Partner, NEA investments, focused on biopharmaceutical investments; previously President and Chief Executive Officer of MedImmune, subsidiary of AstraZeneca Plc, and Executive Vice President of AstraZeneca; Panel of Senior Advisers, Chatham House; Chief Executive and President, MedImmune, USA